en · de · es · fr · pt
cardarine-notes.peptides6908.com › Faq › Preclinical Findings And Safety Signals — Reference Sheet

Preclinical Findings And Safety Signals — Reference Sheet

By Editorial Desk · published 2026-05-25 · last reviewed 2026-07-10 · Faq

This is a working overview of PPARδ, written for readers who want more than a one-paragraph summary but less than a textbook.

Reviewed 2026-07-10. Anything still debated is marked as such rather than presented as settled.

Preclinical Findings and Safety Signals

Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.

Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.

Mechanism and Safety Research

GW501516 acts as an agonist at the peroxisome proliferator-activated receptor delta, a nuclear receptor that regulates gene expression. Activation shifts transcription toward genes involved in fatty acid uptake, oxidation, and energy expenditure. The compound does not bind the androgen receptor and therefore differs from anabolic steroids and SARMs. In rodent models, this metabolic shift has been linked to increased running endurance and reduced fat accumulation. The exact downstream pathways in humans remain incompletely characterized.

Early clinical research explored GW501516 for lipid disorders, obesity, and diabetes. Some short-term human studies reported changes in HDL cholesterol, LDL cholesterol, and triglycerides. The development program was discontinued after rodent studies showed dose-dependent tumor formation in multiple tissues, including liver, bladder, stomach, and skin. These findings raised concerns about long-term cancer risk in humans. Because human exposure data are limited, the clinical significance of the rodent tumors remains uncertain.

Cardarine at a glance

PropertyValueNotes
Primary targetPPARδ (NR1C2)Nuclear receptor involved in lipid metabolism
Preclinical effectIncreased fatty acid oxidationObserved in rodent studies
Key safety signalTumors in rodents after long-term exposureContributed to halted clinical development
Human trial statusNo approved product; development stoppedLimited short-term metabolic data
Sport regulatory statusProhibited at all timesWADA hormone and metabolic modulators class

Background from the literature

==== European guidelines for phenylketonuria ==== The consensus paper was picked up by the Scientific Advisory Committee of the E.S.PKU. The SAC launched an expert group, the creation the first European Guidelines for Phenylketonuria. This led to the first publication of the key statements in the lancet diabetes and endocrinology. By the end of the year, the complete guidelines were published in the Orphanet Journal of Rare Diseases. The publication also received some critical attention from other medical professionals. A second version of the guidelines is already been worked on.

== System overview == In vertebrates, limb position and velocity are encoded by muscle spindle group Ia afferents responding to muscle length and velocity and muscle spindle group II afferents responding mainly to muscle length. There is a similar division of encoding in invertebrates; different subgroups of neurons of the chordotonal organ encode limb position and velocity. Load on a limb is signaled by Golgi tendon organs: type Ib afferents. These proprioceptors respond to the force a muscle is exerting. Similarly, invertebrates have a mechanism to determine limb load: the campaniform sensilla. These proprioceptors are active when a limb experiences resistance. A third role for proprioceptors is to determine when a joint is at a specific position. In vertebrates, this is accomplished by Ruffini endings and Pacinian corpuscles. These proprioceptors are activated when the joint is at a threshold position, usually at the extremes of joint position. Invertebrates use hair plates to accomplish this; a field of bristles located within joints that detects the relative movement of limb segments through the deflection of the associated cuticular hairs.

In addition, composite materials incorporating MOFs with polymers, carbon materials, or magnetic nanoparticles have been developed to improve mechanical stability, facilitate recovery, and enhance overall treatment efficiency. Despite these promising applications, several challenges remain for the large-scale implementation of MOFs in water treatment systems. These include limited stability in aqueous environments for certain frameworks, the cost and scalability of synthesis, and the need for improved durability under realistic operating conditions . Ongoing research efforts are therefore focused on developing more robust MOF structures and scalable production methods to enable their practical deployment in water purification technologies.

Sources: en.wikipedia.org

Related pages on this site

Further detail

== 19th Century == 1848: Maria Mitchell became the first woman elected to the American Academy of Arts and Sciences; she had discovered a new comet the year before. 1850: Margaretta Morris and Maria Mitchell became the first women elected to the American Association for the Advancement of Science. Morris was a renowned entomologist who specialized in agricultural pests and water beetles, the latter of which was cited by Charles Darwin in his novel On the Origin of Species. 1853: Jane Colden was the only female biologist mentioned by Carl Linnaeus in his masterwork Species Plantarum. 1889: Mary Emilie Holmes became the first female Fellow of the Geological Society of America. 1889: Susan La Flesche Picotte became the first Native American woman to become a physician in the United States. 1893: Florence Bascom became the second woman to earn her Ph.D. in geology in the United States, and the first woman to receive a Ph.D. from Johns Hopkins University. Geologists consider her to be the "first woman geologist in this country [America]." 1896: Florence Bascom became the first woman to work for the United States Geological Survey.

In Situ and Ex Situ NMR Techniques NMR technology can be divided into two main experimental approaches in battery research: In Situ NMR and Ex Situ NMR. Each offers unique advantages depending on the research goals.

=== DNA test === The muscle-specific isoform of the dystrophin gene is composed of 79 exons, and DNA testing (blood test) and analysis can usually identify the specific type of mutation of the exon or exons that are affected. DNA testing confirms the diagnosis in most cases.

=== Meteoritic quinones === A proposed alternative source to chemiosmotic energy developing across membranous structures is if an electron acceptor, ferricyanide, is within a vesicle and the electron donor is outside, quinones transported by carbonaceous meteorites pick up electrons and protons from the donor. They would release electrons across the lipid membrane by diffusion to ferricyanide within the vesicles and release protons which produces gradients above pH 2, the process is conducive to the development of proton gradients.

Sources: en.wikipedia.org

Frequently asked questions

What did animal studies show?

Rodent studies reported increased endurance and fat oxidation after GW501516 exposure. Long-term studies also found higher rates of some tumors, which led to halted development.

Has cardarine been tested in humans?

Small short-term human trials examined metabolic markers such as lipids and glucose. The trials did not continue after rodent cancer findings, so long-term human safety is unknown.

Does cardarine improve athletic performance in people?

Controlled human trials have not established a performance benefit. Anecdotal reports exist, but they are not reliable evidence.

What is the main molecular target of cardarine?

It targets PPARδ, a nuclear receptor involved in lipid and energy metabolism. It does not act primarily on androgen receptors. This distinction separates it from SARMs.

Network